Pharmacokinetic Assessment of Ceftazidime in Intermittent Hemodialysis Patients
NCT01507532
·
clinicaltrials.gov ↗
PHASE4
Phase
WITHDRAWN
Status
OTHER
Sponsor class
Stopped
did not enroll a patient
Conditions
Renal Failure
Interventions
OTHER:
pharmacokinetic monitoring
Sponsor
Midwestern University